• Health Economics And Outcomes Research
    Health Economics And Outcomes Research - We support bio-pharma companies with real world evidence
    and economic modeling to maximize product access and value
We support bio-pharma companies with real world evidence
and economic modeling to maximize product access and value

Health Economics and Outcomes Research

  • SmartAnalyst utilizes deep disease and domain knowledge to design and deliver successful projects for our clients.
  • We take a holistic approach to Market Access, with the ability to combine patient, payor, and physician insights and work with our clients to develop economic evidence to demonstrate the value of their products.
  • We have developed and utilized innovative methodologies, such as dynamic disease modeling to forecast epidemiology of complex diseases.
Health Economics and Outcomes Research
The SmartAnalyst Difference:
  • Domain expertise in a variety of therapeutic areas, including complex areas such as oncology
  • Data agnostic - ability to employ leading retrospective patient level databases across the globe
  • Flexibility and focus on the client experience - a collaborative working relationship
  • Extensive track record of success with a highly skilled research team
Our capabilities in Health Economics Modeling include:
  • Longitudinal Data Analysis
  • Cost-effectiveness Analysis
  • Risk Sharing Analysis
  • Budget Impact Models
  • Comparative Effectiveness Models
Our capabilities in Health Economics Modeling
Download Recent Publications
NEWS

Our recent publications 

  •  ISPOR - Asia Pacific 2018, Sept.8-11, 2018, Tokyo- Poster Presentation  

    • Review ofreal-world databases in Japan and South Korea that could be used to informhealthcare resource use and cost inputs for health economic studies - Mazumder D,Bhandari H, Ranjan S, LoPresti M, Smulders M

    • The impact of the cost ofexisting treatment on the results of cost-effectiveness analysis studies forJapan LoPresti M, Mazumder D, Bhandari H,Ranjan S, Smulders M

  • 23rd Congress of European Hematology Association (EHA), June14-17, 2018, Stockholm, Sweden, Europe - AbstractBook -

    •  Quadrant Analysisof Drug Approval and Emerging Treatment Trends in Chronic    Lymphocytic Leukemia– A Retrospective Study on Pivotal Clinical Trials - Maneesha     Chhikara, Debasish Mazumder, Rohit Tyagi

  • 2018 ASCOAnnual Meeting, June 1-5, 2018, Chicago, IL, USA

    • Progression-free Survival as Surrogate Endpoint for OverallSurvival in NSCLC Trials of Anti PD-1 and Anti PD-L1 Agents and the Impact ofLine of Treatment - AnandaroopDasgupta, Nidhi Dhingra, Tom Stinchcombe, Jaideep V Thottasser

  • ISPOR 23rd  Annual International Conference, May 19-23, 2018, Baltimore,US – Poster Presentation    

    • Budget ImpactAnalyses: Inconsistency and bias in choice of reporting measures - Ravi Potluri,Sandip Ranjan, Aakershit Kumar, Mandeep Raj, Hitesh Bhandari







GLOBAL HEADQUARTERS
(New York, USA)

9 East 38th Street, 8th Floor,
New York 10016
Tel.: (212) 331-0010
Fax: (866) 256-9402

EUROPE
(London, UK)

12 Hammersmith Grove,
London, W6 7AP
Mobile: +44-(0)-752-163-8242
Mobile: +44 (0)-772-574-4296

ASIA PACIFIC
(Gurgaon, INDIA)

14th Floor, Tower D, Cyber Green,
DLF City Phase-III,
Gurgaon 122002, Haryana, India
Tel.: 91-124-4313800